Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cal-1 (LVsh5/C46) with or without Busulfan in HIV-1
NCT01734850Phase 2Completed
- Sponsor
- Calimmune
- Start
- Apr 2013
- Primary completion
- Sep 2017
- Modality
- Gene Editing, Gene Silencing, RNA Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Cal-1 in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Calimmune. Started Apr 2013; status: completed.
02
Drugs
Cal-1
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01734850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01734850.